Anti‑oncogenic and pro‑myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcomaAgnese Di Rocco(Sidney Kimmel Cancer Center), Bianca M. Zani(University of L'Aquila)Oncology ReportsJuly 8, 202210.3892/or.2022.8363Cited by 9SaveCiteExport RISWatch citationsRelated PapersKey role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population|Molecular Cancer|2016|83